These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21909362)

  • 1. High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model.
    Schulte J; Sepp KJ; Wu C; Hong P; Littleton JT
    PLoS One; 2011; 6(8):e23841. PubMed ID: 21909362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.
    Weiss KR; Kimura Y; Lee WC; Littleton JT
    Genetics; 2012 Feb; 190(2):581-600. PubMed ID: 22095086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease.
    Miller JP; Yates BE; Al-Ramahi I; Berman AE; Sanhueza M; Kim E; de Haro M; DeGiacomo F; Torcassi C; Holcomb J; Gafni J; Mooney SD; Botas J; Ellerby LM; Hughes RE
    PLoS Genet; 2012; 8(11):e1003042. PubMed ID: 23209424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila.
    Zhang S; Binari R; Zhou R; Perrimon N
    Genetics; 2010 Apr; 184(4):1165-79. PubMed ID: 20100940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation.
    Yamanaka T; Wong HK; Tosaki A; Bauer PO; Wada K; Kurosawa M; Shimogori T; Hattori N; Nukina N
    PLoS One; 2014; 9(4):e93891. PubMed ID: 24705917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
    Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
    Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
    Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologically active molecules that reduce polyglutamine aggregation and toxicity.
    Desai UA; Pallos J; Ma AA; Stockwell BR; Thompson LM; Marsh JL; Diamond MI
    Hum Mol Genet; 2006 Jul; 15(13):2114-24. PubMed ID: 16720620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
    Humbert S; Bryson EA; Cordelières FP; Connors NC; Datta SR; Finkbeiner S; Greenberg ME; Saudou F
    Dev Cell; 2002 Jun; 2(6):831-7. PubMed ID: 12062094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.
    Godin JD; Poizat G; Hickey MA; Maschat F; Humbert S
    EMBO J; 2010 Jul; 29(14):2433-45. PubMed ID: 20531388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
    Bates EA; Victor M; Jones AK; Shi Y; Hart AC
    J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
    Cooper JK; Schilling G; Peters MF; Herring WJ; Sharp AH; Kaminsky Z; Masone J; Khan FA; Delanoy M; Borchelt DR; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 1998 May; 7(5):783-90. PubMed ID: 9536081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    DiFiglia M; Sapp E; Chase KO; Davies SW; Bates GP; Vonsattel JP; Aronin N
    Science; 1997 Sep; 277(5334):1990-3. PubMed ID: 9302293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation.
    Doumanis J; Wada K; Kino Y; Moore AW; Nukina N
    PLoS One; 2009 Sep; 4(9):e7275. PubMed ID: 19789644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.